- Message from the Director
- Chair, Board of Governors Message
- Board of Governors
- Leadership
- Sylvester Locations
- Sylvester by the Numbers
-
- Sylvester Investigator’s Hodgkin Lymphoma Protocol Could Change Care for Relapsed, Refractory Patients
- Sylvester Physician-Scientist Receives Doris Duke Charitable Foundation Grant
- Junior Researcher Lands Competitive Grants for Pancreatic Cancer Focus
- Sylvester Researcher Chosen for Bristol Myers Squibb Foundation’s Career Development Program
- Sylvester Part of Groundbreaking NIH Trial Proving Anal Cancer Can Be Prevented
- The Childhood Cancer Project Focuses On Cures
-
- Health Economist Heads Commission to Examine Global Cancer Care Inequities
- Dr. Chad Ritch Appointed Member of American College of Surgeons Commission on Cancer
- Sylvester Launches New Program To Prevent Breast Cancer In Those At High Risk
- VA Honors Investigator For Gastric Cancer Research
- Keeping Cancer In Its Place: Key Protein Identified
- Phase 1 Program
-
- WHO Taps Sylvester in Global Fight Against Cervical Cancer
- Groundbreaking Research
- Community Outreach
- Orthopaedic Surgeon, Researcher Dr. Francis Hornicek Returns To Miami
- Sarcoma Specialist’s Return Elevates Sylvester Orthopaedic Oncology
- Dr. Marijo Bilusic Joins Sylvester as Genitourinary Site Leader
- Cancer Control Leader Joins Sylvester
- Educational Pathways Fuel Robust Cancer Research Pipeline
- Target: Multiple Myeloma Cure
- Educator
-
- Committed to Survivors’ Quality of Life
- Multidisciplinary Clinic
- Tackling Hispanic Cancer Disparities
- Training The Next Generation of Researchers in Disparities, Equity
- Researcher Drives Efforts To Educate Youth About E-Cigs, Hookahs
- Sylvester Studies Cancer Patient Advocacy Group’s Impact on Outcomes
- Clinic Addresses Sexual Dysfunction In Cancer Survivors
-
Marijo Bilusic, M.D., Ph.D., a boardcertified medical oncologist who treats genitourinary tumors, has joine Sylvester as leader of the Genitourinary Cancers Site Disease Group.
Dr. Bilusic’s current research interests focus on tumor immunology and development of novel immunotherapy approaches for genitourinary and other tumors using therapeutic cancer vaccines, antibodies, or immune modulators. He earned his medical degree at the University of Zagreb School of Medicine in Croatia and completed his Ph.D. training at the University of Split School of Medicine in Croatia. In addition, he completed a postdoctoral research fellowship in physiological genomics at the Medical College of Wisconsin’s Human and Molecular Genetics Center in Milwaukee.
In 2017, Dr. Bilusic received the NIH Director’s Award as a member of the NIH Hematology Oncology Fellowship Team, for extraordinary resourcefulness and initiative. His passion for teaching and mentoring has earned multiple awards at NIH and NCI. He is board certified in medical oncology, hematology, and internal medicine.